-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

ASH Poster Walk on Hemostasis and Thrombosis hosted by Blood VTH (For In-person Participants)

Program: ASH Poster Walks
Hematology Disease Topics & Pathways:
Research, Fundamental Science, clinical trials, Bleeding and Clotting, bleeding disorders, Biological therapies, Anticoagulant Drugs, Translational Research, epidemiology, Non-Biological therapies, Clinical Research, platelet disorders, thromboembolism, Diseases, thrombocytopenias, thrombotic disorders, Therapies, VWD, Transfusion
Saturday, December 9, 2023: 4:00 PM-5:00 PM
Halls G-H - Blood Journals Studio (San Diego Convention Center)
The purpose of this poster walk is to highlight clinical and translational/basic science in hemostasis, thrombosis, and platelet disorders to foster discussion across disciplines and to encourage young investigators to pursue this career path. This poster walk aligns with ASH’s research agenda and will present clinical and basic/translational science abstracts from hemostasis, thrombosis, and platelet disorders. Join us in the Blood Studio located in the main Poster Hall for this in-person poster walk hosted by ASH’s new Blood Vessels, Thrombosis & Hemostasis journal.
1187
Platelet Mitochondria Calcium Uniporter Regulates ITAM-Dependent Platelet Activation and Signaling

Abigail Ajanel Gomez, MS, BS1, Frederik Denorme, PhD, MSc2, Irina Portier, PhD3*, Mia Kowalczyk4*, Sradha Rameshbhatt3*, Yasuhiro Kosaka, PhD1* and Robert A. Campbell, PhD1,5,6,7,8

1Molecular Medicine Program, University of Utah, Salt Lake City, UT
2Department of Neurology, Division of Vascular Neurology, University of Utah, Salt Lake City, UT
3University of Utah, Salt Lake City, UT
4Univeristy of Utah, Salt Lake City, UT
5University of Utah School of Medicine, Salt Lake City, UT
6Department of Medicine, Division of General Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT
7Department of Pathology, University of Utah, Salt Lake City, UT
8Department of Internal Medicine, University of Utah, Salt Lake City, UT
3950
Screening for Key Structural Differences in Thrombosis Versus Hemostasis through Single Platelet Analysis

Md Omar Faruque, MD/PhD*, Irina D Pokrovskaya, M.S.*, Michael W. Webb, Ph.D.* and Brian Storrie, PhD

Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, Little Rock, AR
3973
The Anticoagulant Systems Cooperate Synergistically on Phospholipid Vesicle and Endothelial Cell Membranes, but Not on Platelets

Martha M.S. Sim, MSc1,2*, Dlovan F. D Mahmood, MS2* and Jeremy P. Wood, PhD1,2,3

1Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY
2Saha Cardiovascular Research Center, University of Kentucky, Lexington, KY
3Division of Cardiovascular Medicine Gill Heart and Vascular Institute, University of Kentucky, Lexington, KY
High Risk of Thrombosis in a Prospective Cohort of Adults with Primary Immune Thrombocytopenia

Ingrid Pabinger, MD

Medical University of Vienna, Vienna, Austria
1249
Impact of Blood Group O and Von Willebrand Factor on Bleeding Severity in Patients with Von Willebrand Disease and Bleeding Disorder of Unknown Cause

Dino Mehic, MD1*, Daniel Kraemmer2*, Jasmin Sabrina Rast, MD3*, Silvia Koder4*, Michelle Fuchs5*, Helmuth Haslacher6*, Peter Quehenberger, MD6*, Cihan Ay, MD7*, Ingrid Pabinger, MD1 and Johanna Gebhart, MD3*

1Medical University of Vienna, Vienna, Austria
2Medical University Vienna, Vienna, AUT
3Department of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
4Internal Medicine I, Vienna, AUT
5Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria
6Medical University of Vienna, Vienna, AUT
7Department of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, AUT
Tacrolimus and Danazol Combination As a Second-Line Therapeutic Strategy for Steroid-Resistant or Relapsed Immune Thrombocytopenia: A Prospective, Randomized, Multicenter, Open-Label Study

Xiaohui Zhang, MD

Peking University People's Hospital, Beijing, China
See more of: ASH Poster Walks
<< Previous Poster Walk Application | Next Poster Walk Application >>